Citations 3
P936: TIME TO RESPONSE, DURATION OF RESPONSE, AND PATIENT-REPORTED OUTCOMES WITH DARATUMUMAB PLUS RD VS RD ALONE IN TRANSPLANT-INELIGIBLE PATIENTS WITH NDMM: SUBGROUP ANALYSIS OF THE PHASE 3 MAIA STUDY
Facon, T., Kumar, Seema, Plesner, Torben , Goldschmidt, H., Perrot, A., Venner, Chris , Mace, Joseph R., Tiab, Mourad, Macro, M. , Frenzel, L., Leleu, Xavier , Pei, H., Borgsten, F., Usmani, S. Z., Moreau, Philippe , Bahlis, Nizar Jacques , O’Dwyer, Michael , Weisel, Katja C , Raje, Noopur
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 826-827
P961: CILTACABTAGENE AUTOLEUCEL, A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2-YEAR POST LPI RESULTS FROM THE PHASE 1B/2 CARTITUDE-1 STUDY
Lin, Yaxiong, Martin, Thomas , Berdeja, J. G., Deol, Abhinav , Htut, Myo, Munshi, Nikhil C. , O’Donnell, Elisabeth K., Jackson, C. C., Yeh, Tzu‐Min, Banerjee, Arnob , Zudaire, Enrique, Pacaud, Lida , Usmani, S. Z., Jakubowiak, Andrzej , Agha, Mounzer , Cohen, Adam D. , Htut, Myo , Lesokhin, Alexander M. , Jackson, C.C., Madduri, Deepu , Zhou, C., Jagannath, Sundar
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 851-852
B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Gay, Francesca Maria, Berdeja, J. G., Stefano, V De, Hooper, B, Haltner, A, Kumar, S, Martin, T, Mateos, MV, Moreau, P, Rosta, E, Samjoo, IA, Usmani, S. Z., Weisel, K, Cc, Jackson, Olyslager, Y, Schecter, JM, Vogel, M, Garrett, A, Lee, S, Nesheiwat, T, Pacaud, L, Zhou, C, Valluri, S, Lin, Y, Hari, Parameswaran , Hooper, Becky , Rosta, Emily, Weisel, Katja C , Olyslager, Yunsi, Schecter, JM, Garrett, Ashraf, Lee, S, Nesheiwat, T, Pacaud, Lida , Costa, Luciano J. , Lin, Yi
HemaSphere | April 6, 2022 | Volume: 6 | Issue: No issue available | Pages: 8-8